Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study

Thorax

Volumn 67, Issue , 2018, Pages

  Walter, Joan E ^a   Heuvelmans, Marjolein A ^a   Ten Haaf, Kevin ^b   Vliegenthart, Rozemarijn ^a   Van Der Aalst, Carlijn M ^b   Yousaf Khan, Uraujh ^b   Van Ooijen, Peter M A ^a   Nackaerts, Kristiaan ^c   Groen, Harry J M ^a   De Bock, Geertruida H ^a   De Koning, Harry J ^b   Oudkerk, Matthijs ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

lung cancer

Indexed keywords

AGED; BELGIUM; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; FEMALE; HUMAN; INCIDENCE; LUNG TUMOR; MALE; MIDDLE AGED; MULTIPLE PULMONARY NODULES; NETHERLANDS; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; X-RAY COMPUTED TOMOGRAPHY;

AGED; BELGIUM; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIPLE PULMONARY NODULES; NETHERLANDS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85059329355     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2018-212152     Document Type: Article

References (35)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin 2017; 67: 7-30. doi:10.3322/caac.21387
2. van der Aalst CM, Ten Haaf K, de Koning HJ. Lung cancer screening: latest developments and unanswered questions. Lancet Respir Med 2016; 4: 749-61. doi:10.1016/S2213-2600(16)30200-4
3. Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395-409. doi:10.1056/NEJMoa1102873
4. Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT Screening for lung cancer. JAMA 2012; 307: 2418. doi:10.1001/jama.2012.5521
5. Smith RA, Andrews KS, Brooks D, et al. Cancer screening in the United States, 2017: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 2017; 67: 100-21. doi:10.3322/caac.21392
6. de Koning HJ, Meza R, Plevritis SK, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive services task force. Ann Intern Med 2014; 160: 311-20. doi:10.7326/M13-2316
7. Oudkerk M, Devaraj A, Vliegenthart R, et al. European position statement on lung cancer screening. Lancet Oncol 2017; 18: e754-e766. doi:10.1016/S1470-2045(17)30861-6
8. Walter JE, Heuvelmans MA, de Jong PA, et al. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Lancet Oncol 2016; 17: 907-16. doi:10.1016/S1470-2045(16)30069-9
9. Yousaf-Khan U, van der Aalst C, de Jong PA, et al. Risk stratification based on screening history: the NELSON lung cancer screening study. Thorax 2017; 72: 819-24. doi:10.1136/thoraxjnl-2016-209892
10. Walter JE, Heuvelmans MA, de Bock GH, et al. Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study. Lung Cancer 2018; 125: 103-8. doi:10.1016/j.lungcan.2018.05.007
11. Callister MEJ, Baldwin DR, Akram AR, et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE. Thorax 2015; 70: ii1-54. doi:10.1136/thoraxjnl-2015-207168
12. Walter JE, Heuvelmans MA, Oudkerk M. Small pulmonary nodules in baseline and incidence screening rounds of low-dose CT lung cancer screening. Transl Lung Cancer Res 2017; 6: 42-51. doi:10.21037/tlcr.2016.11.05
13. Henschke CI, Naidich DP, Yankelevitz DF, et al. Early lung cancer action project: initial findings on repeat screenings. Cancer 2001; 92: 153-9.
14. Henschke CI, Yankelevitz DF, Libby DM, McCauley DI, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006; 355: 1763-71. doi:10.1056/NEJMoa060476
15. Wilson DO, Weissfeld JL, Fuhrman CR, et al. The pittsburgh lung screening study (pluss): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med 2008; 178: 956-61. doi:10.1164/rccm.200802-336OC
16. Swensen SJ, Jett JR, Sloan JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002; 165: 508-13. doi:10.1164/ajrccm.165.4.2107006
17. Pinsky PF, Gierada DS, Nath PH, et al. Lung Cancer risk associated with new solid nodules in the national lung screening trial. AJR Am J Roentgenol 2017; 209: 1009-14. doi:10.2214/AJR.17.18252
18. American College of Radiology. LungRADSTM Version 1.0 Assessment Categories Release date: April 28, 2014. 2014. http://www.acr.org/∼/media/ACR/Documents/PDF/QualitySafety/Resources/LungRADS/AssessmentCategories.pdf (. accessed 1 Sep 2016).
19. Horeweg N, van Rosmalen J, Heuvelmans MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 2014; 15: 1332-41. doi:10.1016/S1470-2045(14)70389-4
20. Walter JE, Heuvelmans MA, Bock GH, de BGH, et al. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study. Thorax 2018; 73: 741-7. doi:10.1136/thoraxjnl-2017-211376
21. Libby DM, Wu N, Lee I-J, et al. CT Screening for Lung Cancer. Chest 2006; 129: 1039-42. doi:10.1378/chest.129.4.1039
22. Diederich S, Hansen J, Wormanns D. Resolving small pulmonary nodules: CT features. Eur Radiol 2005; 15: 2064-9. doi:10.1007/s00330-005-2836-4
23. Lee SM, Park CM, Goo JM, et al. Transient part-solid nodules detected at screening thin-section CT for lung cancer: comparison with persistent part-solid nodules. Radiology 2010; 255: 242-51. doi:10.1148/radiol.09090547
24. Zhao YR, Heuvelmans MA, Dorrius MD, et al. Features of resolving and nonresolving indeterminate pulmonary nodules at follow-up CT: the NELSON study. Radiology 2014; 270: 872-9. doi:10.1148/radiol.13130332
25. Walter JE, Heuvelmans MA, Yousaf-Khan U, et al. New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial. J Thorac Oncol 2018; 13: 1410-4. doi:10.1016/j.jtho.2018.05.006
26. Xu DM, Gietema H, de Koning H, et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006; 54: 177-84. doi:10.1016/j.lungcan.2006.08.006
27. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007; 120: 868-74. doi:10.1002/ijc.22134
28. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009; 361: 2221-9. doi:10.1056/NEJMoa0906085
29. Yousaf-Khan U, van der Aalst C, de Jong PA, et al. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval. Thorax 2016; 72: 1-9. doi:10.1136/thoraxjnl-2016-208655
30. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-45. doi:10.2307/2531595
31. Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3: 32-5. doi:10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
32. Lindell RM, Hartman TE, Swensen SJ, et al. 5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size. Chest 2009; 136: 1586-95. doi:10.1378/chest.09-0915
33. Heuvelmans MA, Vliegenthart R, de Koning HJ, et al. Quantification of growth patterns of screen-detected lung cancers: the NELSON study. Lung Cancer 2017; 108: 48-54. doi:10.1016/j.lungcan.2017.02.021
34. Baldwin DR, Devaraj A. Lung cancer risk in new pulmonary nodules: implications for CT screening and nodule management. Lancet Oncol 2016; 17: 9-10. doi:10.1016/S1470-2045(16)30134-6
35. Heuvelmans MA, Oudkerk M, de Jong PA, et al. The impact of radiologists' expertise on screen results decisions in a CT lung cancer screening trial. Eur Radiol 2015; 25: 792-9. doi:10.1007/s00330-014-3467-4